The tissue diagnostics market is expected to reach USD 5.14 Billion by 2022 from USD 3.44 Billion in 2016 at a CAGR of 6.9%.
The Research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Tissue Diagnostics Market, along with revenue estimates & forecasts and market share analysis.
Factors driving the growth of this market include the rising incidence of cancer, growing healthcare expenditure, improving infrastructure for cancer diagnosis, and technological advancements in tissue diagnostics.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1063949
Tissue Diagnostics Market segmentation:
- Based on Products
- Based on Technology
- Based on Disease,
- Based on End Users
- Based on Regions
The Major Players Opearting in the Tissue Diagnostics Market:
Key players in the Tissue Diagnostics Market include Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), Merck (Germany), Sakura Finetek Japan (Japan), Abcam (UK), BD (US), QIAGEN (Netherlands), Sienna Cancer Diagnostics (Australia), Royal Philips (Netherlands), A. Menarini Diagnostics (Italy), Cell Signaling Technology (US), Enzo Life Sciences (US), Master Diagnóstica (Spain), TissueGnostics (Austria), Bio SB (US), MedImmune (US), Cernostics (US), Zenalux Biomedical (US), 3DHISTECH (Hungary), Lunaphore Technologies (Switzerland), BioGenex (US), and Biocare Medical (US).
Roche Diagnostics (Switzerland), Agilent Technologies (U.S.), and Danaher Corporation (U.S.) are the market leaders in the tissue diagnostics market. These companies have business interests across the globe with the U.S. accounting for the largest share of their combined revenues followed by Europe.
New product launches and Merger & Acquisitions are the key growth strategies adopted by major players in the tissue diagnostics market. The strategy of new product launches was mainly adopted by Roche Diagnostics (Switzerland), Agilent Technologies (U.S.), and Danaher Corporation (U.S.). In tissue diagnostics market important players are acquired by some major companies. Merger & Acquisitions strategy was mainly adopted by Danaher Corporation (U.S.) and Agilent Technologies (U.S.). Danaher Corporation acquired Leica Biosystems and Beckman Coulter, and Agilent Technologies acquired Dako. Companies adopted these strategies in order to expand their product portfolio and strengthen their market presence.
Geographical Detailed Analysis for Tissue Diagnostics Market:
North America is the largest regional segment in the Tissue Diagnostics Market followed by Europe
North America will continue to dominate the global market during the forecast period. However, Asia is expected to witness the highest CAGR during the forecast period with growth centered at Japan, China, and India. Factors such as the rising focus of major players in emerging Asian countries and government support are driving the growth of the market in this region.
Read More in Detailed (Tissue Diagnostics):